363 related articles for article (PubMed ID: 34333075)
1. Synergies between therapeutic ultrasound, gene therapy and immunotherapy in cancer treatment.
Zhang N; Wang J; Foiret J; Dai Z; Ferrara KW
Adv Drug Deliv Rev; 2021 Nov; 178():113906. PubMed ID: 34333075
[TBL] [Abstract][Full Text] [Related]
2. Translational Prospects of ultrasound-mediated tumor immunotherapy: Preclinical advances and safety considerations.
Xu W; Zhang X; Hu X; Zhiyi C; Huang P
Cancer Lett; 2019 Sep; 460():86-95. PubMed ID: 31254552
[TBL] [Abstract][Full Text] [Related]
3. New Aspects of Ultrasound-Mediated Targeted Delivery and Therapy for Cancer.
Tian Y; Liu Z; Tan H; Hou J; Wen X; Yang F; Cheng W
Int J Nanomedicine; 2020; 15():401-418. PubMed ID: 32021187
[TBL] [Abstract][Full Text] [Related]
4. Nanotechnology platforms for cancer immunotherapy.
Yang Z; Ma Y; Zhao H; Yuan Y; Kim BYS
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1590. PubMed ID: 31696664
[TBL] [Abstract][Full Text] [Related]
5. Engineering Versatile Nanomedicines for Ultrasonic Tumor Immunotherapy.
Liang J; Qiao X; Qiu L; Xu H; Xiang H; Ding H; Chen Y
Adv Sci (Weinh); 2024 Jan; 11(3):e2305392. PubMed ID: 38041509
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy of malignancy by in vivo gene transfer into tumors.
Hum Gene Ther; 1992 Aug; 3(4):399-410. PubMed ID: 1525212
[TBL] [Abstract][Full Text] [Related]
7. The roles of thermal and mechanical stress in focused ultrasound-mediated immunomodulation and immunotherapy for central nervous system tumors.
Kim C; Lim M; Woodworth GF; Arvanitis CD
J Neurooncol; 2022 Apr; 157(2):221-236. PubMed ID: 35235137
[TBL] [Abstract][Full Text] [Related]
8. Gold nanoparticle mediated cancer immunotherapy.
Almeida JP; Figueroa ER; Drezek RA
Nanomedicine; 2014 Apr; 10(3):503-14. PubMed ID: 24103304
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles for nucleic acid delivery: Applications in cancer immunotherapy.
Mukalel AJ; Riley RS; Zhang R; Mitchell MJ
Cancer Lett; 2019 Aug; 458():102-112. PubMed ID: 31100411
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional nanoparticles for cancer immunotherapy.
Saleh T; Shojaosadati SA
Hum Vaccin Immunother; 2016 Jul; 12(7):1863-75. PubMed ID: 26901287
[TBL] [Abstract][Full Text] [Related]
11. Non-viral gene delivery for cancer immunotherapy.
Wang W; Saeed M; Zhou Y; Yang L; Wang D; Yu H
J Gene Med; 2019 Jul; 21(7):e3092. PubMed ID: 30991453
[TBL] [Abstract][Full Text] [Related]
12. Genetically modified dendritic cells for cancer immunotherapy.
Ribas A
Curr Gene Ther; 2005 Dec; 5(6):619-28. PubMed ID: 16457651
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound-augmented cancer immunotherapy.
Liu B; Du F; Feng Z; Xiang X; Guo R; Ma L; Zhu B; Qiu L
J Mater Chem B; 2024 Apr; 12(15):3636-3658. PubMed ID: 38529593
[TBL] [Abstract][Full Text] [Related]
14. Recent advances and challenges of repurposing nanoparticle-based drug delivery systems to enhance cancer immunotherapy.
Lim S; Park J; Shim MK; Um W; Yoon HY; Ryu JH; Lim DK; Kim K
Theranostics; 2019; 9(25):7906-7923. PubMed ID: 31695807
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticle-Mediated Remodeling of the Tumor Microenvironment to Enhance Immunotherapy.
Musetti S; Huang L
ACS Nano; 2018 Dec; 12(12):11740-11755. PubMed ID: 30508378
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in sonodynamic immunotherapy.
Du JR; Wang Y; Yue ZH; Zhang HY; Wang H; Sui GQ; Sun ZX
J Cancer Res Clin Oncol; 2023 Apr; 149(4):1645-1656. PubMed ID: 35831762
[TBL] [Abstract][Full Text] [Related]
17. Phase-Transformation Nanoparticle-Mediated Sonodynamic Therapy: An Effective Modality to Enhance Anti-Tumor Immune Response by Inducing Immunogenic Cell Death in Breast Cancer.
Si Y; Yue J; Liu Z; Li M; Du F; Wang X; Dai Z; Hu N; Ju J; Gao S; Wang X; Yuan P
Int J Nanomedicine; 2021; 16():1913-1926. PubMed ID: 33707946
[TBL] [Abstract][Full Text] [Related]
18. Nano-Immune-Engineering Approaches to Advance Cancer Immunotherapy: Lessons from Ultra-pH-Sensitive Nanoparticles.
Li S; Bennett ZT; Sumer BD; Gao J
Acc Chem Res; 2020 Nov; 53(11):2546-2557. PubMed ID: 33063517
[TBL] [Abstract][Full Text] [Related]
19. Chemical Strategies to Enhance the Therapeutic Efficacy of Toll-like Receptor Agonist Based Cancer Immunotherapy.
Lee SN; Jin SM; Shin HS; Lim YT
Acc Chem Res; 2020 Oct; 53(10):2081-2093. PubMed ID: 32966047
[TBL] [Abstract][Full Text] [Related]
20. Mitochondria-targeted and ultrasound-responsive nanoparticles for oxygen and nitric oxide codelivery to reverse immunosuppression and enhance sonodynamic therapy for immune activation.
Ji C; Si J; Xu Y; Zhang W; Yang Y; He X; Xu H; Mou X; Ren H; Guo H
Theranostics; 2021; 11(17):8587-8604. PubMed ID: 34373760
[No Abstract] [Full Text] [Related]
[Next] [New Search]
